Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Selective 5-HT1D receptor agonists from MS&D useful for migraine

Dec. 18, 1998

Chirocaine receives first regulatory approval in Sweden

Dec. 18, 1998

Lilly patents novel mGluR modulators

Dec. 18, 1998

Patent claims relating to use of Avant's TP-20 in stroke allowed

Dec. 17, 1998

Another market launch for Orion's COMT inhibitor

Dec. 17, 1998

Zeneca's new pain-relieving agents revealed in patent literature

Dec. 17, 1998

Studies using 5-ht6 antagonist Ro-04-6790 provide new clues about receptor function

Dec. 17, 1998

NPS Pharmaceuticals updates epilepsy program

Dec. 17, 1998

Novel glutamate receptor antagonist shows excellent potential as antiepileptic agent

Dec. 15, 1998

Merckle launches new treatment for narcolepsy in Germany

Dec. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...